These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16584291)

  • 1. Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-beta (TGF-beta) type II receptor.
    Ogorelkova M; Zwaagstra J; Elahi SM; Dias C; Guilbaut C; Lo R; Collins C; Jaramillo M; Mullick A; O'Connor-McCourt M; Massie B
    Oligonucleotides; 2006; 16(1):2-14. PubMed ID: 16584291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of antisense transforming growth factor beta receptor-II (TGFbetaRII) expressing plasmid on experimental liver fibrosis].
    Jiang W; Wang JY; Yang CQ; Liu WB; Wang YQ; He BM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):137-40. PubMed ID: 15059294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short hairpin RNA causes the methylation of transforming growth factor-beta receptor II promoter and silencing of the target gene in rat hepatic stellate cells.
    Kim JW; Zhang YH; Zern MA; Rossi JJ; Wu J
    Biochem Biophys Res Commun; 2007 Jul; 359(2):292-7. PubMed ID: 17533113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting transforming growth factor βRII expression inhibits the activation of hepatic stellate cells and reduces collagen synthesis.
    Fu R; Wu J; Ding J; Sheng J; Hong L; Sun Q; Fang H; Xiang D
    Exp Biol Med (Maywood); 2011 Mar; 236(3):291-7. PubMed ID: 21378033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of RNA interference in nasopharyngeal carcinoma cell lines using reporter genes].
    Yin ZH; Ren CP; Li F; Jiang WH; Yang XY; Feng XL; Yao KT
    Ai Zheng; 2005 Mar; 24(3):371-5. PubMed ID: 15757546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components.
    Jazag A; Kanai F; Ijichi H; Tateishi K; Ikenoue T; Tanaka Y; Ohta M; Imamura J; Guleng B; Asaoka Y; Kawabe T; Miyagishi M; Taira K; Omata M
    Nucleic Acids Res; 2005 Aug; 33(15):e131. PubMed ID: 16113239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transforming growth factor beta (TGFbeta1) expression and extracellular matrix secretion in human peritoneal mesothelial cells by pcDU6 vector-mediated TGFbeta1 shRNA and by pcDNA3.1(-)-mediated antisense TGFbeta1 RNA.
    Liu F; Liu H; Peng Y; Yuan F; Liu Y; Duan S
    Adv Perit Dial; 2005; 21():41-52. PubMed ID: 16686283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling.
    Truty MJ; Lomberk G; Fernandez-Zapico ME; Urrutia R
    J Biol Chem; 2009 Mar; 284(10):6291-300. PubMed ID: 19088080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
    Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
    Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
    Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
    Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short hairpin RNA modulates transforming growth factor beta signaling in life-threatening liver failure in mice.
    Mizuguchi Y; Yokomuro S; Mishima T; Arima Y; Shimizu T; Kawahigashi Y; Kanda T; Yoshida H; Takizawa T; Tajiri T
    Gastroenterology; 2005 Nov; 129(5):1654-62. PubMed ID: 16285963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
    Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
    Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
    Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
    Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.
    Machitani M; Sakurai F; Katayama K; Tachibana M; Suzuki T; Matsui H; Yamaguchi T; Mizuguchi H
    Virus Res; 2013 Dec; 178(2):357-63. PubMed ID: 24055658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.